Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Carlos Fay is a pioneering urologic surgeon and researcher whose work centers on advancing robotic surgical techniques to improve outcomes in complex urologic oncology. His most impactful contribution lies in the use of indocyanine green (ICG) fluorescence angiography to assess ureteric vascularity during robot-assisted radical cystectomy. His landmark 2019 study, cited 89 times, demonstrated that this real-time imaging technique significantly reduces the rate of uretero-enteric strictures—the most common complication requiring reoperation after bladder removal. Dr. Fay has also made notable strides in salvage surgery for recurrent prostate cancer, describing a novel robotic approach for high-extended retroperitoneal and pelvic lymph node dissection in patients with "node-only" recurrence. His expertise extends to robotic renal artery aneurysm repair and the management of oligometastatic castrate-resistant prostate cancer through adrenal metastasectomy, where he achieved a durable biochemical response. With a growing citation impact and a focus on minimizing surgical morbidity through innovative intraoperative technologies, Dr. Fay is shaping the future of minimally invasive urologic oncology.